The risk of cognitive impairment in older community-dwelling women after benzodiazepine use

Long-term benzodiazepine (BZD) use has been associated with cognitive impairment that was reversible [1, 21 or not [3]. Few cohort studies have examined the association between BZD use & incident cognitive decline or dementia [4]. Chronic BZD users had a significantly increased risk of cognitive...

Full description

Saved in:
Bibliographic Details
Published in:Age and ageing 2009-03, Vol.38 (2), p.226-228
Main Authors: Lagnaoui, Rajaa, Tournier, Marie, Moride, Yola, Wolfson, Christina, Ducruet, Thierry, Bégaud, Bernard, Moore, Nicholas
Format: Article
Language:English
Subjects:
Activities of daily living
Age Distribution
Aged
Aged, 80 and over
Benzodiazepines
Benzodiazepines - administration & dosage
Benzodiazepines - adverse effects
Cognition Disorders - epidemiology
Cognitive ability
Cognitive impairment
Cohort Studies
Dementia
Dementia - epidemiology
Drug abuse
Education
Estrogens
Female
Humans
Incidence
Institutionalization
Older women
Prescription drugs
Quebec - epidemiology
Residence Characteristics
Risk assessment
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Long-term benzodiazepine (BZD) use has been associated with cognitive impairment that was reversible [1, 21 or not [3]. Few cohort studies have examined the association between BZD use & incident cognitive decline or dementia [4]. Chronic BZD users had a significantly increased risk of cognitive impairment, while episodic or recurrent users had not [5]. In the French community-dwelling persons, BZD use was associated with an increased risk of dementia [6]. Nevertheless, the study design did not allow us to rule out a protopathic bias, whereby BZDs could be prescribed for early symptoms of cognitive impairment resulting in a spurious association. Another study reported a lower incidence of dementia in older persons using BZDs [7]. Since subjects exposed only at baseline were not distinguished from those exposed both at baseline & follow-up assessments, a depletion of susceptible effect may explain the protective effect finding [8], as BZDs may have been discontinued in subjects with incident cognitive impairment. To help clarify the association between BZD use & cognitive decline, a case-control analysis was carried out using data from a large representative cohort of Canadian older women, in order to examine the association between BZD use & the occurrence of cognitive decline including dementia. Adapted from the source document.
ISSN:0002-0729
1468-2834
DOI:10.1093/ageing/afn277